Here's Why Emergent Biosolutions Dropped as Much as 11.8% Today
Shares of public health threat neutralizer Emergent Biosolutions (NYSE: EBS) fell nearly 12% today for, well, no compelling reason at this time. Sometimes stocks go up, and sometimes they go down. But it's important to remember that single-day movements have little effect on the long-term performance of a company.
If you really wanted to reach, then there is some news in the company's field. Researchers at the University of Nebraska-Lincoln reported that an experimental flu vaccine could provide lifetime immunity to influenza strains. In other words, a universal flu shot.
Source: Fool.com
Emergent Biosolutions Inc. Aktie
Die Emergent Biosolutions Inc. Aktie erhält eine Reihe von Buy-Einschätzungen, die die Sell-Zahlen übertreffen.
Ein positives, wenn auch bescheidenes, Potenzial für Emergent Biosolutions Inc. mit einem Kursziel von 7 € im Vergleich zum aktuellen Kurs von 6.88 €.